Rhenman & Partners Asset Management AB as of Dec. 31, 2013
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 83 positions in its portfolio as reported in the December 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Regeneron Pharmaceuticals (REGN) | 4.0 | $10M | 37k | 275.24 | |
Celgene Corporation | 3.2 | $8.3M | 49k | 168.96 | |
Gilead Sciences (GILD) | 3.2 | $8.2M | 109k | 75.15 | |
CVS Caremark Corporation (CVS) | 3.0 | $7.7M | 107k | 71.57 | |
Biogen Idec (BIIB) | 3.0 | $7.6M | 27k | 279.74 | |
Johnson & Johnson (JNJ) | 2.9 | $7.3M | 80k | 91.60 | |
NPS Pharmaceuticals | 2.9 | $7.3M | 240k | 30.36 | |
BioMarin Pharmaceutical (BMRN) | 2.8 | $7.0M | 100k | 70.27 | |
Alexion Pharmaceuticals | 2.6 | $6.7M | 50k | 133.06 | |
Pharmacyclics | 2.5 | $6.3M | 60k | 105.78 | |
Alkermes (ALKS) | 2.3 | $5.9M | 145k | 40.66 | |
Aegerion Pharmaceuticals | 2.1 | $5.3M | 75k | 70.96 | |
Keryx Biopharmaceuticals | 2.0 | $5.2M | 400k | 12.95 | |
Salix Pharmaceuticals | 1.9 | $4.9M | 55k | 89.95 | |
Ariad Pharmaceuticals | 1.9 | $4.8M | 700k | 6.82 | |
Theravance | 1.8 | $4.7M | 132k | 35.65 | |
Express Scripts Holding | 1.8 | $4.6M | 65k | 70.25 | |
Incyte Corporation (INCY) | 1.7 | $4.3M | 85k | 50.64 | |
Medtronic | 1.7 | $4.3M | 75k | 57.39 | |
Merck & Co (MRK) | 1.7 | $4.3M | 85k | 50.05 | |
Bristol Myers Squibb (BMY) | 1.5 | $3.8M | 72k | 53.15 | |
UnitedHealth (UNH) | 1.3 | $3.3M | 44k | 75.30 | |
Boston Scientific Corporation (BSX) | 1.3 | $3.3M | 275k | 12.02 | |
Forest Laboratories | 1.3 | $3.3M | 55k | 60.04 | |
Intuitive Surgical (ISRG) | 1.2 | $3.1M | 8.0k | 384.12 | |
Covidien | 1.2 | $3.1M | 45k | 68.11 | |
WellPoint | 1.2 | $3.0M | 32k | 92.38 | |
Infinity Pharmaceuticals (INFIQ) | 1.1 | $2.9M | 210k | 13.81 | |
AmerisourceBergen (COR) | 1.1 | $2.8M | 40k | 70.30 | |
Thermo Fisher Scientific (TMO) | 1.1 | $2.8M | 25k | 111.36 | |
Allergan | 1.1 | $2.8M | 25k | 111.08 | |
Zimmer Holdings (ZBH) | 1.1 | $2.8M | 30k | 93.20 | |
Insulet Corporation (PODD) | 1.1 | $2.8M | 75k | 37.11 | |
Becton, Dickinson and (BDX) | 1.1 | $2.8M | 25k | 110.48 | |
Thoratec Corporation | 1.1 | $2.7M | 75k | 36.60 | |
Aetna | 1.1 | $2.7M | 40k | 68.60 | |
Dynavax Technologies Corporation | 1.1 | $2.7M | 1.4M | 1.96 | |
Dex (DXCM) | 1.1 | $2.7M | 77k | 35.42 | |
Varian Medical Systems | 1.1 | $2.7M | 35k | 77.69 | |
Hca Holdings (HCA) | 1.0 | $2.6M | 55k | 47.71 | |
Teva Pharmaceutical Industries (TEVA) | 1.0 | $2.6M | 65k | 40.08 | |
PAREXEL International Corporation | 1.0 | $2.6M | 58k | 45.17 | |
Cyberonics | 1.0 | $2.6M | 40k | 65.50 | |
Baxter International (BAX) | 1.0 | $2.6M | 37k | 69.54 | |
St. Jude Medical | 1.0 | $2.5M | 40k | 61.95 | |
CIGNA Corporation | 0.9 | $2.4M | 27k | 87.48 | |
Agilent Technologies Inc C ommon (A) | 0.9 | $2.3M | 40k | 57.20 | |
Omnicare | 0.9 | $2.2M | 37k | 60.35 | |
Hyperion Therapeutics | 0.9 | $2.2M | 110k | 20.22 | |
Celldex Therapeutics | 0.8 | $2.2M | 90k | 24.21 | |
Exelixis (EXEL) | 0.8 | $2.1M | 350k | 6.13 | |
Nektar Therapeutics (NKTR) | 0.8 | $2.2M | 190k | 11.35 | |
Integra LifeSciences Holdings (IART) | 0.8 | $2.1M | 45k | 47.71 | |
ACADIA Pharmaceuticals (ACAD) | 0.8 | $2.1M | 85k | 24.99 | |
McKesson Corporation (MCK) | 0.8 | $2.1M | 13k | 161.38 | |
Centene Corporation (CNC) | 0.8 | $2.1M | 35k | 58.94 | |
Ligand Pharmaceuticals In (LGND) | 0.8 | $2.0M | 38k | 52.61 | |
PerkinElmer (RVTY) | 0.7 | $1.9M | 45k | 41.22 | |
Array BioPharma | 0.7 | $1.8M | 360k | 5.01 | |
Eli Lilly & Co. (LLY) | 0.7 | $1.8M | 35k | 51.00 | |
Auxilium Pharmaceuticals | 0.7 | $1.8M | 85k | 20.74 | |
Community Health Systems (CYH) | 0.7 | $1.8M | 45k | 39.27 | |
C.R. Bard | 0.7 | $1.7M | 13k | 133.92 | |
Abiomed | 0.7 | $1.7M | 65k | 26.74 | |
Myriad Genetics (MYGN) | 0.7 | $1.7M | 81k | 20.98 | |
Supernus Pharmaceuticals (SUPN) | 0.7 | $1.7M | 225k | 7.54 | |
Actavis | 0.7 | $1.7M | 10k | 168.00 | |
Hologic (HOLX) | 0.6 | $1.6M | 72k | 22.35 | |
ImmunoGen | 0.6 | $1.5M | 100k | 14.67 | |
Orexigen Therapeutics | 0.6 | $1.4M | 250k | 5.63 | |
Cepheid | 0.6 | $1.4M | 30k | 46.73 | |
Endologix | 0.6 | $1.4M | 81k | 17.44 | |
Haemonetics Corporation (HAE) | 0.5 | $1.3M | 30k | 42.13 | |
Threshold Pharmaceuticals | 0.5 | $1.2M | 250k | 4.67 | |
Trovagene | 0.5 | $1.1M | 200k | 5.74 | |
Volcano Corporation | 0.4 | $983k | 45k | 21.84 | |
Newlink Genetics Corporation | 0.3 | $880k | 40k | 22.00 | |
Allscripts Healthcare Solutions (MDRX) | 0.3 | $850k | 55k | 15.45 | |
Lexicon Pharmaceuticals | 0.2 | $540k | 300k | 1.80 | |
Synta Pharmaceuticals | 0.2 | $524k | 100k | 5.24 | |
Novadaq Technologies | 0.2 | $412k | 25k | 16.48 | |
Anthera Pharmaceutcls | 0.1 | $366k | 119k | 3.07 | |
Endocyte | 0.1 | $267k | 25k | 10.68 |